Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study on Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection

NCT01760109 is registered in ClinicalTrials.gov with Xiangbei Welman Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT01760109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01760109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study on Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection
Lead sponsor
Xiangbei Welman Pharmaceutical Co., Ltd
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2011
Completion date
June 30, 2016
Enrollment
2,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory tract infections, urinary tract infections